# MK0653A (Ezetimibe (+) Simvastatin) Compared to an Approved Drug (Atorvastatin) for the Treatment of High Cholesterol (0653A-051)(COMPLETED)

> **NCT00092690** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 1902 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** MK0653A, ezetimibe (+) simvastatin
- **DRUG:** Comparator: atorvastatin

## Key facts

- **NCT ID:** NCT00092690
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** 2004-03
- **Final completion:** 2004-03
- **Target enrollment:** 1902 (ACTUAL)
- **Last updated:** 2024-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00092690

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00092690, "MK0653A (Ezetimibe (+) Simvastatin) Compared to an Approved Drug (Atorvastatin) for the Treatment of High Cholesterol (0653A-051)(COMPLETED)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00092690. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*